Latest Research & Analysis

30-Sep-2021 - No Recent SEC Investigative Records Found – 127 Companies As of the date of the response in the table below, we received Freedom of Information Act (FOIA) responses from the SEC to suggest the absence of recent SEC investigative activity.  If you think any of these companies...

30-Sep-2021 - Colgate-Palmolive Company – CL:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

30-Sep-2021 - Computer Task Group, Inc. – CTG:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

30-Sep-2021 - Hilton Worldwide Holdings, Inc. – HLT:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in...

30-Sep-2021 - Mastercard Incorporated – MA:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

30-Sep-2021 - Myriad Genetics, Inc. – MYGN:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

30-Sep-2021 - NASDAQ, Inc. – NDAQ:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the Freedom...

30-Sep-2021 - Nektar Therapeutics – NKTR:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the...

Pages